Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/15050914

Download in:

View as

General Info

PMID
15050914